- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01959568
Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery.
Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery: Randomised Clinical Trial of Safety
Purpose: to assess the efficacy and safety of double tamponade versus silicone oil tamponade.
Design: parallel-group study with balanced [1:1] stratified block randomization. Eligible participants are all adults aged 18 or over with first diagnosed rhegmatogenous total retinal detachment with retinal breaks located both in upper and lower retina. Also investigators include those patients with total retinal detachment with proliferative vitreoretinopathy (PVR) in which it is impossible to remove epiretinal membranes completely during the surgery (with arbitrary retinal breaks localization). Exclusion criteria are severe concomitant eye pathologies (glaucoma, diabetic retinopathy, macular hole, traumas etc) and eye length more than 27mm.
Patients are randomized in two groups (test group and control group).
In the test group patients undergo subtotal vitrectomy, epiretinal membrane removal, perfluorodecalin (PFD) tamponade, retinal photocoagulation. After that the surgeon replaces ½ of PFD volume by "conventional" SO (with density less than one of water). The result is vitreous cavity (VC) filled in a half with PFD and in another half - with SO. In the control group patients undergo subtotal vitrectomy, epiretinal membrane removal, PFD tamponade, retinal photocoagulation and PFD-SO exchange, so the result is VC filled with "conventional" or heavy SO, depending on predominant retinal breaks location. 30 days after the surgery in both groups tamponing agents are removed from VC and VC is filled with sulfur hexafluoride gas (SF6) which dissolves during 1 month. Follow-up is at least 12 months.
Along with standard examinations, after SF6 gas dissolution investigators perform spectral optical coherence tomography (OCT) and microperimetry. With OCT investigators measure thickness of retinal inner and outer nuclear layers. With microperimetry investigators determine light sensitivity in 12° and 4° zones from the fixation point.
Outcome measures: reattachment rate, best corrected visual acuity (BCVA), intraocular pressure (IOP), thicknesses of inner and outer nuclear layers according to the OCT, light sensitivity according to microperimetry, the rate of cataract formation in phakic eyes and the rate of tamponing agents emulsification.
For final analysis each group will include 145 participants.
OCT, microperimetry data and visual acuity will be compared between the groups using Student's t-test; proportions will be compared using exact Fisher's test.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators include in the study all successive patients operated by the same surgeon. The study takes place in the S.N. Fyodorov "Eye Microsurgery" Federal State Institution located in Moscow, Russian Federation.
Patients are randomized in two groups with stratified block randomization. Strata were defined by combination of two binary prognostic factors: duration of retinal detachment (less than 3 months and ≥ 3 months) and PVR (present/absent).
Early interim analysis will be performed in order to reveal possible adverse effect of long-term PFD tamponade. For interim report success will mean the rate of post-surgical BCVA >/= 20.200. Groups sizes for interim analysis will be 35 patients in each group. For interim analysis the investigators choose group sizes able to reveal 30% absolute difference in functional success rate with one-sided test (to detect possible toxicity of double tamponade for the retina) having power of 0.8 and significance level of p=0.05. In the final analysis success will mean retinal reattachment.
For final analysis each group will include 145 participants, so that the investigators are able to detect 15% difference in reattachment rate with power of 0.8 and significance level of p=0.05. Group sizes were computed with exact Fisher's test function in G*Power 3.1.7 software (Erdfelder, Faul, & Buchner).
OCT is performed with Cirrus HD-OCT system (Zeiss Meditec Inc). Microperimetry is performed with MP-1 microperimeter (Nidek). All the examinations are assessed by one ophthalmologist.
The allocation concealment is implemented with the help of a third party, who stores the randomization list and prepares envelopes containing directions what method of tamponade to employ in each particular patient. Patients are blind to the method of tamponade.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Pavel V Lyskin, PhD
- Phone Number: +79165558019
- Email: plyskin@yahoo.com
Study Contact Backup
- Name: Elena G Kazimirova, MD
- Phone Number: +79165898410
- Email: lena.kazimirova@gmail.com
Study Locations
-
-
-
Moscow, Russian Federation, 127486
- Recruiting
- SN Fyodorov "Eye Microsurgery" State Institution
-
Contact:
- Pavel V Lyskin, PhD
- Phone Number: +79165558019
- Email: plyskin@yahoo.com
-
Contact:
- Elena G Kazimirova, MD
- Phone Number: +79165898410
- Email: lena.kazimirova@gmail.com
-
Principal Investigator:
- Pavel V Lyskin, PhD
-
Sub-Investigator:
- Elena G Kazimirova, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Adults aged 18 or over with firstly diagnosed rhegmatogenous total retinal detachment:
- with retinal breaks located both in upper and lower retina; OR
- with PVR which was impossible to remove completely during the surgery.
Exclusion Criteria:
- severe concomitant eye pathologies (glaucoma, diabetic retinopathy, macular hole, traumas); OR
- eye length more than 27mm.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Double tamponade
Vitrectomy and tamponade: subtotal vitrectomy, epiretinal membrane removal, perfluorodecalin tamponade, retinal photocoagulation.
After that the surgeon replaces ½ of perfluorodecalin volume by silicone oil.
|
In the double tamponade arm the result of surgery is vitreous cavity filled in a half with perfluorodecalin and in another half - with silicone oil. In the silicone oil tamponade arm the result of surgery is vitreous cavity filled with "conventional" or heavy silicone oil, depending on predominant retinal breaks location.
Other Names:
|
ACTIVE_COMPARATOR: Silicone oil tamponade
Vitrectomy and tamponade: subtotal vitrectomy, epiretinal membrane removal, perfluorodecalin tamponade, retinal photocoagulation and perfluorodecalin-silicone oil exchange.
|
In the double tamponade arm the result of surgery is vitreous cavity filled in a half with perfluorodecalin and in another half - with silicone oil. In the silicone oil tamponade arm the result of surgery is vitreous cavity filled with "conventional" or heavy silicone oil, depending on predominant retinal breaks location.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Retinal reattachment rate
Time Frame: in 1 month after tamponade removal.
|
in 1 month after tamponade removal.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percentage of patients with best corrected visual acuity >/= 20.200
Time Frame: in 1 month after tamponade removal
|
in 1 month after tamponade removal
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of patients with intraocular pressure >/= 25 mm Hg
Time Frame: in 1 month after tamponade removal.
|
in 1 month after tamponade removal.
|
|
Percentage of phakic eyes in which cataract occurred during tamponade
Time Frame: During tamponade removal.
|
During tamponade removal.
|
|
Percentage of eyes with tamponing substances emulsification
Time Frame: During tamponade removal.
|
During tamponade removal.
|
|
Thickness of retinal inner and outer nuclear layers
Time Frame: in 1 month after tamponade removal
|
Measured with Optical Coherence Tomography
|
in 1 month after tamponade removal
|
Retinal light sensitivity
Time Frame: in 1 month after tamponade removal
|
Measured with microperimetry
|
in 1 month after tamponade removal
|
Collaborators and Investigators
Investigators
- Principal Investigator: Pavel V Lyskin, PhD, SN Fyodorov "Eye Microsurgery" State Institution
- Study Director: Valery D Zakharov, Professor, SN Fyodorov "Eye Microsurgery" State Institution
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- #8, 04/09/2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retinal Detachment
-
The S.N. Fyodorov Eye Microsurgery State InstitutionUnknownRhegmatogenous Retinal DetachmentRussian Federation
-
Meir Medical CenterUnknownRhegmatogenous Retinal DetachmentIsrael
-
University of Campinas, BrazilCompletedRhegmatogenous Retinal Detachment
-
Ain Shams UniversityNot yet recruitingRhegmatogenous Retinal Detachment
-
Shahid Beheshti University of Medical SciencesUnknownPseudophakic Retinal Detachment | Aphakic Retinal DetachmentIran, Islamic Republic of
-
Dar El Oyoun HospitalCairo UniversityCompletedRetinal Detachment Multiple BreaksEgypt
-
Universidade Federal do ParanáCompletedRhegmatogenous Retinal Detachment
-
Singapore National Eye CentreCompleted
-
Samsung Medical CenterCompletedRhegmatogenous Retinal Detachment
-
Vitreous -Retina- Macula Consultants of New YorkRegeneron PharmaceuticalsWithdrawnFibrovascular Pigment Epithelial DetachmentUnited States
Clinical Trials on Vitrectomy and tamponade
-
Helse Stavanger HFHaukeland University HospitalCompleted
-
Kyorin UniversityCompleted
-
Centre Hospitalier Universitaire DijonCompletedPostoperative Complications | Intraocular Pressure,France
-
University of Kansas Medical CenterRecruiting
-
Wenzhou Medical UniversityNot yet recruitingCataract | Vitreoretinal Abnormality
-
Sun Yat-sen UniversityCompletedHigh Myopia | Macular Holes | Macular DetachmentChina
-
Peking University People's HospitalThe First Affiliated Hospital with Nanjing Medical University; Peking University... and other collaboratorsRecruiting
-
Helse Stavanger HFOslo University Hospital; University Hospital of North Norway; Haukeland University... and other collaboratorsCompleted
-
Faculty Hospital Kralovske VinohradyCharles University, Czech RepublicRecruiting